374
Views
6
CrossRef citations to date
0
Altmetric
Drug Profiles

An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults

, &
Pages 177-186 | Received 20 Sep 2015, Accepted 25 Nov 2015, Published online: 08 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong & Jingqing Zhang. (2021) Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. International Journal of Nanomedicine 16, pages 4959-4984.
Read now

Articles from other publishers (5)

Reena Singh, Seema Gupta & Pradeep Kumar. (2021) The Role of Nanotechnology in Antiviral Regime: An Overview. Nano LIFE 12:01.
Crossref
Dongliang Cheng, Bing Han, Wei Zhang & Wei Wu. (2021) Clinical effects of NTCP‐inhibitor myrcludex B. Journal of Viral Hepatitis 28:6, pages 852-858.
Crossref
Florina-Daniela Cojocaru, Doru Botezat, Ioannis Gardikiotis, Cristina-Mariana Uritu, Gianina Dodi, Laura Trandafir, Ciprian Rezus, Elena Rezus, Bogdan-Ionel Tamba & Cosmin-Teodor Mihai. (2020) Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Pharmaceutics 12:2, pages 171.
Crossref
Sreekumar Othumpangat, Sidhartha D. Ray & John D. Noti. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 269 282 .
Gautam Ray. (2016) 5-year efficacy of entecavir in Indian patients with chronic hepatitis B. Indian Journal of Gastroenterology 35:3, pages 190-194.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.